Trademark Overview
On Thursday, April 18, 2024, a trademark application was filed for EXIMMIUM with the United States Patent and Trademark Office. The USPTO has given the EXIMMIUM trademark a serial number of 79404774. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, November 4, 2025. This trademark is owned by Eximmium Biotechnologies GmbH. The EXIMMIUM trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Human healthcare services; animal healthcare services; medical services; medical and healthcare services; human hygiene and beauty care; advisory services relating to medical services; medical services in the field of oncology; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical diagnostic services.
Medical and veterinary preparations, namely, pharmaceutical and biological preparations for the treatment of cancer and infectious disease; Pharmaceuticals and natural remedies in the nature of pharmaceutical and biological preparations for the treatment of cancer and infectious disease; biotechnological preparations for the treatment of cancer and infectious disease for medical use; antibodies for medical purposes; diagnostic agents for medical use; diagnostic preparations and materials, namely, diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; anti-cancer drugs; Pharmaceutical compounds for treating cancer; pharmaceutical preparations and substances for use in oncology; clinical diagnostic reagents for medical use
Chemical substances, materials and preparations, namely, chemicals for industrial purposes; chemical compositions and materials, namely, chemicals for use in science; chemical components, namely, chemicals for producing a radio-labelled monoclonal antibody for industrial or scientific use; tagged antibodies for scientific purposes for laboratory use; monoclonal antibodies for scientific use; tagged antibodies for scientific use; immunological antibodies for scientific purposes, other than for medical use; monoclonal antibodies for scientific purposes for diagnostic use, other than medical use; antibodies for scientific purposes, other than for medical or veterinary use; diagnostic preparations for scientific purposes; clinical diagnostics, namely, diagnostic reagents for scientific use other than for medical or veterinary use; diagnostic reagents for in-vitro use for scientific use, other than medical use; diagnostic reagents, other than for medical use in kit form, namely, diagnostic ...
Science and technology services, namely, scientific research and development; natural science services, namely, scientific research; medical and pharmacological research services; information on the subject of scientific research in the field of biochemistry and biotechnology; research relating to biotechnology; biotechnology product testing; research and development in the field of biotechnology; research and development in the pharmaceutical and biotechnology fields; research and development services in the field of antibody technology; research and development services in the field of antibodies; scientific research laboratory services relating to the production of monoclonal antibodies; research and development in the field of diagnostic preparations
